BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer

  March 12, 2008

   · 

  7 min read
• Drug Development

  Celsion Corporation Commences Global Phase III Study for Primary Liver Cancer

  March 12, 2008

   · 

  1 min read
• Drug Development

  Urigen Pharmaceuticals, Inc. Announces Positive Phase II Clinical Trial Results with URG101

  March 12, 2008

   · 

  1 min read
• Policy

  Amgen to Discuss Romiplostim Application at FDA ODAC Meeting

  March 12, 2008

   · 

  1 min read
• Drug Development

  Avexa Limited Reports Superior Results in ATC Phase IIb Clinical Trial Update

  March 12, 2008

   · 

  1 min read
• Bio NC

  Laboratory Corporation of America Holdings’s Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

  March 12, 2008

   · 

  1 min read
• Business

  Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement

  March 12, 2008

   · 

  1 min read
• Drug Development

  AstraZeneca PLC Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)

  March 12, 2008

   · 

  4 min read
• Genetown

  Initial Trading of RXi PharmaceuticalsBegins Today on the NASDAQ Capital Market Under Symbol RXII

  March 12, 2008

   · 

  1 min read
• Drug Development

  ADVENTRX Pharmaceuticals Inc. to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology

  March 12, 2008

   · 

  3 min read